Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Home Newsfeeds DICE Therapeutics Q2 EPS $(0.58)

DICE Therapeutics Q2 EPS $(0.58)

DICE Therapeutics (NASDAQ:DICE) reported quarterly losses of $(0.58) per share.

byBenzinga Newsdesk

August 11, 2022

1 minute read

DICE Therapeutics (NASDAQ:DICE) reported quarterly losses of $(0.58) per share.

Ladenburg Thalmann Downgrades Allarity Therapeutics to Neutral

By Benzinga Newsdesk

August 23, 11:20 AM

Ladenburg Thalmann analyst Aydin Huseynov downgrades Allarity Therapeutics (NASDAQ:ALLR) from Buy to Neutral.

ALLR

Earnings

Earnings Outlook For Arch Capital Group

By Benzinga Insights

February 13, 10:00 AM

Arch Capital Group (NASDAQ:ACGL) is set to give its latest quarterly earnings report on Wednesday, 2024-02-14. Here’s what…

ACGL

Why Hooker Furnishings Are Trading Lower By 15%? Here Are Other Stocks Moving In Friday’s Mid-Day Session

By Lisa Levin

September 8, 1:56 PM

Gainers Biocept, Inc. (NASDAQ: BIOC) shares jumped 97.6% to $1.6608 after the company announced non-exclusive licensing agreement for CNSide with Plus Therapeutics.

AGBA

Sigma Additive Solutions, Inc. Announces Reverse 1-For-20 Stock Split To Regain Nasdaq Compliance And Facilitate Recently Announced Strategic Transactions

By Happy Mohamed

September 21, 8:36 AM

Sigma Additive Solutions, Inc. (NASDAQ:SASI) ("Sigma" or the "Company") will effect a 1-for-20 reverse stock split of its outstanding common stock to seek to regain compliance with the

SASI

DICE Therapeutics Q2 EPS $(0.58)

Related Posts

Ladenburg Thalmann Downgrades Allarity Therapeutics to Neutral

Earnings Outlook For Arch Capital Group

Why Hooker Furnishings Are Trading Lower By 15%? Here Are Other Stocks Moving In Friday’s Mid-Day Session

Sigma Additive Solutions, Inc. Announces Reverse 1-For-20 Stock Split To Regain Nasdaq Compliance And Facilitate Recently Announced Strategic Transactions